COMMUNIQUÉS West-GlobeNewswire

-
CARBIOS présente les résultats de son Assemblée Générale du 19 juin 2025 et la composition de son Conseil d’administration
20/06/2025 -
Carbios presents the results of its Annual General Meeting of 19 June 2025 and the composition of its Board of Directors
20/06/2025 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/06/2025 -
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
20/06/2025 -
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
20/06/2025 -
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
19/06/2025 -
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
19/06/2025 -
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
19/06/2025 -
Anosh Ahmed Drives Major Community Impact Across Chicago Through Healthcare, Education, and Economic Relief Programs
19/06/2025 -
Labviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025
19/06/2025 -
Unyte Health Launches Sonocea® Enhanced Rest and Restore Protocol™: Revolutionary Approach for Nervous System Regulation
19/06/2025 -
Kansas State University Veterinary Health Center Adopts Instinct EMR, Retires Legacy System
19/06/2025 -
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
19/06/2025 -
CrazyBulk “Legal Steroid Alternatives” for Muscle Growth: A Safer Shift in Bodybuilding and Performance Nutrition 2025
19/06/2025 -
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
19/06/2025 -
VitalHub Completes Acquisition of Induction
19/06/2025 -
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
19/06/2025 -
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
19/06/2025 -
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2025
Pages